Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

Fig. 2

Identification of anlotinib-responsive genes in anlotinib-treated NCI-H1975 cells. a Flow diagram of the analysis for screening out 769 anlotinib-responsive genes. b Heat map representation of 769 anlotinib-responsive gene expressions upon NCI-H1975 cells and anlotinib-treated NCI-H1975 cells. c GO analysis of 769 anlotinib-responsive genes. d KEGG pathway analysis of 769 anlotinib-responsive genes

Back to article page